Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Phoenix Pharmacologics Inc.,

Phoenix Pharmacologics Inc., with its principal headquarterslocated in, San Diego, California, is a privately-held emerging
biopharmaceutical company that specializes in developing
drugs to treat cancer and related disorders. Two of its protein
drugs are in late stage clinical trials: ADI-PEG 20 for the
treatment of hepatocellular carcinoma and metastatic melanoma,
and Uricase-PEG 20 for the treatment of hyperuricemia
associated with gout and tumor lysis syndrome. Another cancer
drug is in preclinical development. The Company has also
initiated a computerized small molecule drug-design program
based on the x-ray crystallographic structure of large target
molecules. The Company plans to establish partnerships
with pharmaceutical companies to commercialize its drugs
worldwide.


Contact Details:
4215 Sorrento Valley Blvd
San Diego
California
92121
United States of America
Tel: (858) 452-6688
Fax:(858) 452-3199
Email:
WWW:

www.phoenixpharmaco.com/




Loading...

BioNews Results for Phoenix Pharmacologics Inc.,:

Arcadia Biosciences and Vilmorin Announce Strategic Alliance to Develop and Market Nitrogen Use Efficient Whea
Yahoo! Canada:  Nov 20 2009 7:08AM Matching: phoenix inc
Germany-Based caprotec bioanalytics Opens US Subsidiary in Burlington, Massachusetts; Appoints President
Austin Business Journal:  Nov 19 2009 12:51PM Matching: phoenix inc
TechMARK movers: Psion shares fall despite positive statement
Find:  Nov 19 2009 7:15PM Matching: phoenix inc
Mesoblast Limited (ASX:MSB) Sustained Six-Month Improvement In Heart Muscle Function With Revascor, 'Off-The-S
Pharma Live:  Nov 19 2009 6:44AM Matching: phoenix inc
Mesoblast Limited (ASX:MSB) Sustained Six-Month Improvement In Heart Muscle Function With Revascor, 'Off-The-S
Pharmacy Choice:  Nov 18 2009 2:25PM Matching: phoenix inc
Promote your company here: BioNewsCast - Press Release Distribution

View more Phoenix Pharmacologics Inc., news.

Phoenix Pharmacologics Inc., Patents:

US Patent No.Title
7204980 Methods for inhibiting viral replication in vivo
6913915 PEG-modified uricase
6737259 Modified arginine deiminase

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1375 times since April 2007, the link to the organisation's website has been followed 346 times

Recent Search Terms used to find this page: Phoenix Pharmacologics | Phoenix Pharmacologics Inc | Phoenix Pharmacologics | PHOENIX PHARMACOLOGICS INC | Phoenix Pharmacologics | phoenix pharmacologics | phoenix pharmacologics | phoenix pharmacologics | phoenix phamacologics | phoenix pharmacologics | .

Search for more companies in San Diego

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Phoenix Pharmacologics Inc.,

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.